Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy

Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies, and its most common complication is infection. We aimed to evaluate the patients who underwent PTC regarding their cultures, prophylaxis, and anti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infectious diseases & clinical microbiology 2022-12, Vol.4 (4), p.274-279
Hauptverfasser: Araz, Halime, Eren, Tülay, Kocagül-Çelikbaş, Aysel, Özdemir, Nuriye
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 279
container_issue 4
container_start_page 274
container_title Infectious diseases & clinical microbiology
container_volume 4
creator Araz, Halime
Eren, Tülay
Kocagül-Çelikbaş, Aysel
Özdemir, Nuriye
description Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies, and its most common complication is infection. We aimed to evaluate the patients who underwent PTC regarding their cultures, prophylaxis, and antibiotics used for treatment. In this cross-sectional study, patients who underwent PTC and were followed up in a medical oncology outpatient clinic between 2010-2017 were evaluated retrospectively. Patients' data were obtained from the hospital record system (FONET), epicrisis forms, and patient progress files. A total of 93 patients were included in the study. Prophylaxis was given in 50% of the cases. Complications developed in 68% of the cases after the intervention, and the infectious disease clinic consulted all. Blood cultures were obtained from 89% of the febrile patients; however, bile cultures were obtained only from 29%. The rate of resistant Gram-negative enteric bacteria in growing microorganisms was 52% (n=13). It was determined that 65% of the initiated empirical treatments were appropriate for the growth of microorganisms. The growth rate was significantly higher in blood cultures than in bile cultures. The lower growth rate in bile culture was attributed to the low number of bile cultures. There was no significant difference regarding the growth rate and drug resistance of the microorganisms. Therefore, we think giving antibiotics as treatment rather than prophylaxis is more appropriate. Taking cultures will ensure that patients receive appropriate antibiotic therapy for the causative agent.
doi_str_mv 10.36519/idcm.2022.176
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10986684</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A733806971</galeid><sourcerecordid>A733806971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c343t-f0fa52ec107a733128b6aac5b828e931844f5fe7c744790ed3ae3ac5e9a4e1213</originalsourceid><addsrcrecordid>eNptkk9v1DAQxSMEolXplSOyxIXLLv6TOMkJtatSKhWxgiJxs2adSWLk2IudbNkvw2fF6ZaqSJUPHnl-8_TGeln2mtGlkAWr35tGD0tOOV-yUj7LjrmU5ULm8sfzR_VRdhrjT0opr6UoRPUyOxKVFKJk7Dj7c7EDO8FovCO-JefW-4Z8GwPCQMA15NxYA2FPbgLokVy5FvXMRvIVLYzYkNGTNQY9jeDQT3EGXexxmyQ1WfXeguuM7wJs-_2d4jr4VFr4bSK5NDt0xDiyTji6MZJbM_bkM1jTOXB6_yp70YKNeHp_n2TfP17crD4trr9cXq3Orhda5GJctLSFgqNmtIRSCMarjQTQxabiFdaCVXneFi2WuszzsqbYCECR-lhDjowzcZJ9OOhup82AjU5eAli1DWZI2ysPRv3fcaZXnd8pRutKyipPCu_uFYL_NWEc1WCiRmsP_6IEzRkXglOa0LcHtAOLyrjWJ0k94-osua-orMvZ0vIJKp0GB6O9w9ak96cGdPAxBmwf7DOq7vKi5ryoOS8q5SUNvHm89AP-Lx3iL2JLv0A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3041233200</pqid></control><display><type>article</type><title>Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy</title><source>PubMed Central Open Access</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Araz, Halime ; Eren, Tülay ; Kocagül-Çelikbaş, Aysel ; Özdemir, Nuriye</creator><creatorcontrib>Araz, Halime ; Eren, Tülay ; Kocagül-Çelikbaş, Aysel ; Özdemir, Nuriye</creatorcontrib><description>Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies, and its most common complication is infection. We aimed to evaluate the patients who underwent PTC regarding their cultures, prophylaxis, and antibiotics used for treatment. In this cross-sectional study, patients who underwent PTC and were followed up in a medical oncology outpatient clinic between 2010-2017 were evaluated retrospectively. Patients' data were obtained from the hospital record system (FONET), epicrisis forms, and patient progress files. A total of 93 patients were included in the study. Prophylaxis was given in 50% of the cases. Complications developed in 68% of the cases after the intervention, and the infectious disease clinic consulted all. Blood cultures were obtained from 89% of the febrile patients; however, bile cultures were obtained only from 29%. The rate of resistant Gram-negative enteric bacteria in growing microorganisms was 52% (n=13). It was determined that 65% of the initiated empirical treatments were appropriate for the growth of microorganisms. The growth rate was significantly higher in blood cultures than in bile cultures. The lower growth rate in bile culture was attributed to the low number of bile cultures. There was no significant difference regarding the growth rate and drug resistance of the microorganisms. Therefore, we think giving antibiotics as treatment rather than prophylaxis is more appropriate. Taking cultures will ensure that patients receive appropriate antibiotic therapy for the causative agent.</description><identifier>ISSN: 2667-646X</identifier><identifier>EISSN: 2667-646X</identifier><identifier>DOI: 10.36519/idcm.2022.176</identifier><identifier>PMID: 38633711</identifier><language>eng</language><publisher>Turkey: DOC Design and Informatics Co. Ltd</publisher><subject>Antibiotic Prophylaxis ; Bacteremia ; Blood ; Cancer ; Drug resistance in microorganisms ; Health aspects ; Infection ; Medical examination ; Medical records ; Medical research ; Medicine, Experimental ; Original ; Sulbactam ; Tazobactam</subject><ispartof>Infectious diseases &amp; clinical microbiology, 2022-12, Vol.4 (4), p.274-279</ispartof><rights>Copyright © 2024 Infectious Diseases and Clinical Microbiology.</rights><rights>COPYRIGHT 2022 DOC Design and Informatics Co. Ltd.</rights><rights>Copyright © 2024 Infectious Diseases and Clinical Microbiology 2024</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0002-0088-1149 ; 0000-0002-9235-9592 ; 0000-0003-4774-5950 ; 0000-0002-7448-5210</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986684/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10986684/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38633711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Araz, Halime</creatorcontrib><creatorcontrib>Eren, Tülay</creatorcontrib><creatorcontrib>Kocagül-Çelikbaş, Aysel</creatorcontrib><creatorcontrib>Özdemir, Nuriye</creatorcontrib><title>Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy</title><title>Infectious diseases &amp; clinical microbiology</title><addtitle>Infect Dis Clin Microbiol</addtitle><description>Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies, and its most common complication is infection. We aimed to evaluate the patients who underwent PTC regarding their cultures, prophylaxis, and antibiotics used for treatment. In this cross-sectional study, patients who underwent PTC and were followed up in a medical oncology outpatient clinic between 2010-2017 were evaluated retrospectively. Patients' data were obtained from the hospital record system (FONET), epicrisis forms, and patient progress files. A total of 93 patients were included in the study. Prophylaxis was given in 50% of the cases. Complications developed in 68% of the cases after the intervention, and the infectious disease clinic consulted all. Blood cultures were obtained from 89% of the febrile patients; however, bile cultures were obtained only from 29%. The rate of resistant Gram-negative enteric bacteria in growing microorganisms was 52% (n=13). It was determined that 65% of the initiated empirical treatments were appropriate for the growth of microorganisms. The growth rate was significantly higher in blood cultures than in bile cultures. The lower growth rate in bile culture was attributed to the low number of bile cultures. There was no significant difference regarding the growth rate and drug resistance of the microorganisms. Therefore, we think giving antibiotics as treatment rather than prophylaxis is more appropriate. Taking cultures will ensure that patients receive appropriate antibiotic therapy for the causative agent.</description><subject>Antibiotic Prophylaxis</subject><subject>Bacteremia</subject><subject>Blood</subject><subject>Cancer</subject><subject>Drug resistance in microorganisms</subject><subject>Health aspects</subject><subject>Infection</subject><subject>Medical examination</subject><subject>Medical records</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Original</subject><subject>Sulbactam</subject><subject>Tazobactam</subject><issn>2667-646X</issn><issn>2667-646X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNptkk9v1DAQxSMEolXplSOyxIXLLv6TOMkJtatSKhWxgiJxs2adSWLk2IudbNkvw2fF6ZaqSJUPHnl-8_TGeln2mtGlkAWr35tGD0tOOV-yUj7LjrmU5ULm8sfzR_VRdhrjT0opr6UoRPUyOxKVFKJk7Dj7c7EDO8FovCO-JefW-4Z8GwPCQMA15NxYA2FPbgLokVy5FvXMRvIVLYzYkNGTNQY9jeDQT3EGXexxmyQ1WfXeguuM7wJs-_2d4jr4VFr4bSK5NDt0xDiyTji6MZJbM_bkM1jTOXB6_yp70YKNeHp_n2TfP17crD4trr9cXq3Orhda5GJctLSFgqNmtIRSCMarjQTQxabiFdaCVXneFi2WuszzsqbYCECR-lhDjowzcZJ9OOhup82AjU5eAli1DWZI2ysPRv3fcaZXnd8pRutKyipPCu_uFYL_NWEc1WCiRmsP_6IEzRkXglOa0LcHtAOLyrjWJ0k94-osua-orMvZ0vIJKp0GB6O9w9ak96cGdPAxBmwf7DOq7vKi5ryoOS8q5SUNvHm89AP-Lx3iL2JLv0A</recordid><startdate>20221201</startdate><enddate>20221201</enddate><creator>Araz, Halime</creator><creator>Eren, Tülay</creator><creator>Kocagül-Çelikbaş, Aysel</creator><creator>Özdemir, Nuriye</creator><general>DOC Design and Informatics Co. Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0088-1149</orcidid><orcidid>https://orcid.org/0000-0002-9235-9592</orcidid><orcidid>https://orcid.org/0000-0003-4774-5950</orcidid><orcidid>https://orcid.org/0000-0002-7448-5210</orcidid></search><sort><creationdate>20221201</creationdate><title>Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy</title><author>Araz, Halime ; Eren, Tülay ; Kocagül-Çelikbaş, Aysel ; Özdemir, Nuriye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c343t-f0fa52ec107a733128b6aac5b828e931844f5fe7c744790ed3ae3ac5e9a4e1213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibiotic Prophylaxis</topic><topic>Bacteremia</topic><topic>Blood</topic><topic>Cancer</topic><topic>Drug resistance in microorganisms</topic><topic>Health aspects</topic><topic>Infection</topic><topic>Medical examination</topic><topic>Medical records</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Original</topic><topic>Sulbactam</topic><topic>Tazobactam</topic><toplevel>online_resources</toplevel><creatorcontrib>Araz, Halime</creatorcontrib><creatorcontrib>Eren, Tülay</creatorcontrib><creatorcontrib>Kocagül-Çelikbaş, Aysel</creatorcontrib><creatorcontrib>Özdemir, Nuriye</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Infectious diseases &amp; clinical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Araz, Halime</au><au>Eren, Tülay</au><au>Kocagül-Çelikbaş, Aysel</au><au>Özdemir, Nuriye</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy</atitle><jtitle>Infectious diseases &amp; clinical microbiology</jtitle><addtitle>Infect Dis Clin Microbiol</addtitle><date>2022-12-01</date><risdate>2022</risdate><volume>4</volume><issue>4</issue><spage>274</spage><epage>279</epage><pages>274-279</pages><issn>2667-646X</issn><eissn>2667-646X</eissn><abstract>Percutaneous transhepatic cholangiography (PTC) is an invasive procedure used in patients with obstructive jaundice in the progress of some malignancies, and its most common complication is infection. We aimed to evaluate the patients who underwent PTC regarding their cultures, prophylaxis, and antibiotics used for treatment. In this cross-sectional study, patients who underwent PTC and were followed up in a medical oncology outpatient clinic between 2010-2017 were evaluated retrospectively. Patients' data were obtained from the hospital record system (FONET), epicrisis forms, and patient progress files. A total of 93 patients were included in the study. Prophylaxis was given in 50% of the cases. Complications developed in 68% of the cases after the intervention, and the infectious disease clinic consulted all. Blood cultures were obtained from 89% of the febrile patients; however, bile cultures were obtained only from 29%. The rate of resistant Gram-negative enteric bacteria in growing microorganisms was 52% (n=13). It was determined that 65% of the initiated empirical treatments were appropriate for the growth of microorganisms. The growth rate was significantly higher in blood cultures than in bile cultures. The lower growth rate in bile culture was attributed to the low number of bile cultures. There was no significant difference regarding the growth rate and drug resistance of the microorganisms. Therefore, we think giving antibiotics as treatment rather than prophylaxis is more appropriate. Taking cultures will ensure that patients receive appropriate antibiotic therapy for the causative agent.</abstract><cop>Turkey</cop><pub>DOC Design and Informatics Co. Ltd</pub><pmid>38633711</pmid><doi>10.36519/idcm.2022.176</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-0088-1149</orcidid><orcidid>https://orcid.org/0000-0002-9235-9592</orcidid><orcidid>https://orcid.org/0000-0003-4774-5950</orcidid><orcidid>https://orcid.org/0000-0002-7448-5210</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2667-646X
ispartof Infectious diseases & clinical microbiology, 2022-12, Vol.4 (4), p.274-279
issn 2667-646X
2667-646X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10986684
source PubMed Central Open Access; PubMed Central; Alma/SFX Local Collection
subjects Antibiotic Prophylaxis
Bacteremia
Blood
Cancer
Drug resistance in microorganisms
Health aspects
Infection
Medical examination
Medical records
Medical research
Medicine, Experimental
Original
Sulbactam
Tazobactam
title Evaluation of Blood Stream and Biliary Tract Infections Related to Percutaneous Transhepatic Cholangiography and Prophylaxis Given in Patients with Malignancy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A17%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20Blood%20Stream%20and%20Biliary%20Tract%20Infections%20Related%20to%20Percutaneous%20Transhepatic%20Cholangiography%20and%20Prophylaxis%20Given%20in%20Patients%20with%20Malignancy&rft.jtitle=Infectious%20diseases%20&%20clinical%20microbiology&rft.au=Araz,%20Halime&rft.date=2022-12-01&rft.volume=4&rft.issue=4&rft.spage=274&rft.epage=279&rft.pages=274-279&rft.issn=2667-646X&rft.eissn=2667-646X&rft_id=info:doi/10.36519/idcm.2022.176&rft_dat=%3Cgale_pubme%3EA733806971%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3041233200&rft_id=info:pmid/38633711&rft_galeid=A733806971&rfr_iscdi=true